Full Story

ACCCeXchange
Blog
Oncology Issues
Podcast

Welcome, !

Log out

Join/Renew
Learn
Attend
Connect
Advocate
News & Media
About

Share

In This Section

Join/Renew
Learn
Attend
Connect
Advocate
News & Media
About

Home / News & Media / Oncology Newsfeed / Full Story

FDA Approves Durvalumab + Chemotherapy for Endometrial Cancer
FDA Approves Pembrolizumab + Chemotherapy for Primary Advanced or Recurrent Endometrial Carcinoma
FDA Approves Selpercatinib for RET Fusion-Positive Thyroid Cancer
FDA Approves Imetelstat for Myelodysplastic Syndromes with Transfusion-Dependent Anemia
FDA Approves Lisocabtagene Maraleucel for Relapsed or Refractory Mantle Cell Lymphoma
FDA Approves Tarlatamab-dlle for Extensive-Stage Small Cell Lung Cancer
PharmaEssentia Educational Resource
On-demand: Practical Insights for Operationalizing a Lymphedema Surveillance Program
FDA Approves Lisocabtagene Maraleucel for Follicular Lymphoma
New Resources for Acute Myeloid Leukemia Care Providers
FDA Approves Tisotumab Vedotin-tftv for Recurrent or Metastatic Cervical Cancer
FDA Approves Lutetium Lu 177 Dotatate for Pediatric Patients with Astroenteropancreatic Neuroendocrine Tumors
FDA Approves Nogapendekin Alfa Inbakicept-pmln for Invasive Bladder Cancer
FDA Approves Alectinib for ALK-positive Non-Small Cell Lung Cancer
FDA Approves Idecabtagene vicleucel for Relapsed or Refractory Multiple Myeloma
The Patient Perspective: Evaluating Time and Treatment While Living with Metastatic Breast Cancer
FDA Approves Fam-trastuzumab deruxtecan-nxki for Unresectable or Metastatic HER2-positive Solid Tumors
FDA Approves Mirvetuximab Soravtansine-gynx for Certain Ovarian Cancers
Small Cell Lung Cancer: A guide for patients and their families
Let's Chat CAR T

1
2 (current)
3
4
5
6
7
8
9
10

1801 Research Boulevard, Suite 400, Rockville, MD 20850
Tel: 301.984.9496 Fax: 301.770.1949 Email Us

Corporate Members
Oncology State Societies
Privacy Policy

Copyright © 2024 Association of Cancer Care Centers. All Rights Reserved.